These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31136648)

  • 41. Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study.
    Sáiz-Chumillas RM; Barrio J; Fernández-Salazar L; Arias L; Sierra Ausín M; Piñero C; Fuentes Coronel A; Mata L; Vásquez M; Carbajo A; Alcaide N; Cano N; Nuñez A; Fradejas P; Ibáñez M; Hernández L; Sicilia B
    Gastroenterol Hepatol; 2023 Feb; 46(2):102-108. PubMed ID: 35569540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.
    Everhov ÅH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olén O
    Scand J Gastroenterol; 2019 Jan; 54(1):55-63. PubMed ID: 30700170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Tsai L; Nguyen NH; Ma C; Prokop LJ; Sandborn WJ; Singh S
    Dig Dis Sci; 2022 Jun; 67(6):2451-2461. PubMed ID: 34379220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study.
    Hong SJ; Cho SM; Choe BH; Jang HJ; Choi KH; Kang B; Kim JE; Hwang JH
    J Korean Med Sci; 2018 Apr; 33(18):e132. PubMed ID: 29713253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009.
    Jakobsen C; Paerregaard A; Munkholm P; Faerk J; Lange A; Andersen J; Jakobsen M; Kramer I; Czernia-Mazurkiewicz J; Wewer V
    Inflamm Bowel Dis; 2011 Dec; 17(12):2541-50. PubMed ID: 21381152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.
    Belnour S; Slater R; Tharmaratnam K; Karl-Heinz Auth M; Muhammed R; Spray C; Wang D; Zeeshan Ijaz U; Probert C; Allen S
    United European Gastroenterol J; 2024 Jul; 12(6):780-792. PubMed ID: 38922802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid rise in incidence of Irish paediatric inflammatory bowel disease.
    Hope B; Shahdadpuri R; Dunne C; Broderick AM; Grant T; Hamzawi M; O'Driscoll K; Quinn S; Hussey S; Bourke B
    Arch Dis Child; 2012 Jul; 97(7):590-4. PubMed ID: 22550323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory Bowel Disease Across the Age Continuum: Similarity and Disparity.
    Sonavane AD; Sonawane P; Amarapurkar DN
    Indian J Pediatr; 2018 Nov; 85(11):989-994. PubMed ID: 29572605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease.
    Zhao J; Ng SC; Lei Y; Yi F; Li J; Yu L; Zou K; Dan Z; Dai M; Ding Y; Song M; Mei Q; Fang X; Liu H; Shi Z; Zhou R; Xia M; Wu Q; Xiong Z; Zhu W; Deng L; Kamm MA; Xia B
    Inflamm Bowel Dis; 2013 Aug; 19(9):1839-45. PubMed ID: 23669403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
    Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
    BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients.
    Herzog D; Fournier N; Buehr P; Rueger V; Koller R; Heyland K; Nydegger A; Braegger CP;
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):926-931. PubMed ID: 28471820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic Pattern of Early Versus Later-Onset Pediatric Inflammatory Bowel Disease in a Eurasian Country.
    S Akkelle B; Ertem D; Volkan B; Tutar E
    J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):e61-e66. PubMed ID: 35809240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].
    Guan DX; Yu FH; Wang GL; Zhou J; Wang DY; Nie XL; Xu XW
    Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):493-498. PubMed ID: 28728256
    [No Abstract]   [Full Text] [Related]  

  • 56. Natural history of pediatric-onset inflammatory bowel disease: a systematic review.
    Abraham BP; Mehta S; El-Serag HB
    J Clin Gastroenterol; 2012 Aug; 46(7):581-9. PubMed ID: 22772738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.
    Banerjee R; Pal P; Hilmi I; Ghoshal UC; Desai DC; Rahman MM; Dutta U; Mohiuddin SA; Al Mohannadi M; Philip M; Ramesh GN; Niriella MA; De Silva AP; de Silva HJ; Pisespongsa P; Limsrivilai J; Aniwan S; Nawarathne M; Fernandopulle N; Aye TT; Ni N; Al Awadhi S; Joshi N; Ngoc PTV; Kieu TV; Nguyen AD; Abdullah M; Ali E; Zeid A; Sollano JD; Saberi B; Omar M; Mohsin MN; Aftab H; Wai TM; Shastri YM; Chaudhuri S; Ahmed F; Bhatia SJ; Travis SPL;
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1004-1015. PubMed ID: 35178742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features and treatment of inflammatory bowel disease in a low-incidence area: A hospital-based retrospective cohort study in Taiwan.
    Yen HH; Hsu TC; Chen MW; Su PY; Chen YY
    Medicine (Baltimore); 2021 Mar; 100(10):e25090. PubMed ID: 33725901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.